• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Enanta Pharma(ENTA.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov18
Enanta Pharma released FY2025 Annual Earnings on November 17 After-Market (EST), actual revenue USD 65.32 M (forecast USD 66.15 M), actual EPS USD -3.838 (forecast USD -3.7725)
00:00
Enanta Pharma released FY2025 Q4 earnings on November 17 After-Market (EST), actual revenue USD 15.13 M (forecast USD 15.97 M), actual EPS USD -0.8746 (forecast USD -1.014)
00:00
Nov10
Enanta Pharma to release FY2025 Q4 earnings on November 17 After-Market EST, forecast revenue USD 15.97 M, EPS USD -1.014
00:05
Oct20
Enanta to Present New Data on RSV Drug Candidates at IDWeek
11:01
Oct7
Enanta Pharmaceuticals Reports Positive Clinical Trial Results for RSV Research Drugs
11:00
Oct2
Enanta Pharmaceuticals Completes $74.75 Million Increased Offering of Common Stock
20:01

Schedules & Filings

Schedules
Filings
Feb9
Earning Release(EST)

FY2026 Q1 Earning Release

Nov17
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 15.13 M, Net Income -18.7 M, EPS -0.8746

Aug11
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 18.31 M, Net Income -18.26 M, EPS -0.8539

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More